Confluent Medical

What Confluent Medical does

Confluent Medical Technologies is a contract development and manufacturing organization (CDMO) specializing in interventional catheter-based medical devices and implants. Founded in 1991 as Nitinol Devices and Components (NDC), the company was acquired by Johnson & Johnson, spun off in 2008, and rebranded as Confluent Medical Technologies in 2016 following the acquisition of Interface Balloon Catheters. Headquartered in Fremont, California with 501-1,000 employees, the company serves medical device OEMs across cardiovascular, neurovascular, electrophysiology, peripheral vascular, structural heart, and interventional urology segments. The company is privately held, backed by private equity firm TPG, and operates a global manufacturing footprint spanning the United States, Costa Rica, and India with over 400,000 sq. ft. of combined capacity.

The company's product portfolio spans four core technology pillars: Nitinol components (laser-cut stents, frames, hypotubes, and wire using proprietary SE508 ELI high-purity implant-grade alloy), polymer tubing (FilmCast PTFE, polyimide including the NMP-free Ultra Polyimide, and the FilmCast Select customization program), biomedical textiles (wovens, knits, braids, non-wovens, and CALADRIX electrospun materials via The Electrospinning Company partnership), and complex/balloon catheters. A January 2024 strategic partnership with ATI involving over $50 million in investment gives Confluent control over the Nitinol supply chain from raw alloy melt through finished device assembly, targeting a 300%+ capacity increase by 2027. The company holds ASTM F2063 medical-grade Nitinol compliance and offers REACH-compliant material options, positioning it for EU MDR and EPA regulatory shifts.

Confluent generates revenue through three streams: contract manufacturing services for components and assemblies (prototyping through high-volume production with 4-6 week Nitinol tubing lead times and 2-week rapid prototyping), materials sales via the Confluent Materials Web Shop for standard polymer and Nitinol materials, and product development services including design optimization, finite element analysis, and regulatory support. Pricing is quote-based with multi-year contracts; no public pricing exists. Go-to-market is enterprise field sales led by CCO Doug Hutchison, supported by participation in MD&M industry events, technical content marketing through a dedicated Tech Center, and consultative engagement with OEMs from concept through commercialization. The acquisition history (Interface Balloon Catheters, Corpus Medical, Tube Hollows International, ETE Medical) and the 2026 appointment of Tom Testa as COO indicate continued operational scaling under TPG ownership.

Name

Confluent Medical

Legal name

Confluent Medical Technologies

Website

https://confluentmedical.com

Company type

Private

Founded year

1991

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Confluent Medical Technologies is a TPG-backed CDMO that designs and manufactures catheter-based interventional medical devices and implants — including Nitinol components, polymer tubing, biomedical textiles, and balloon/complex catheters — for medical device OEMs across cardiovascular, neurovascular, electrophysiology, peripheral vascular, and structural heart applications.

Ownership category

akta.pro rank

Product category

Medical Device Contract Manufacturing

NAICS

Plastics Pipe, Pipe Fitting, and Unlaminated Profile Shape Manufacturing (32612), Medical Equipment and Supplies Manufacturing (3391)

SIC

Plastics Products, Nec (3089)

akta.pro primary industry

Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK)

Keywords

• Nitinol medical components
• Catheter manufacturing
• Biomedical textiles
• Polymer tubing
• Medical device CDMO

Headquarters

HQ city

Fremont

HQ country

United States

HQ region

North America

Offices6 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D

Revenue model

1. Contract Manufacturing Services: Confluent operates as a CDMO (Contract Development and Manufacturing Organization) providing manufacturing services for medical device components. Revenue is generated through manufacturing fees for components and assemblies across Nitinol, polymers, textiles, and catheters. Services range from prototyping through high-volume production.
2. Materials Sales: Sale of medical device materials including Nitinol tubing, wire, polymer tubing (PTFE, polyimide), and specialty materials through the Confluent Materials Web Shop (shop.confluentmedical.com).
3. Product Development Services: Engineering and design services including design optimization, finite element analysis, transformation temperature tuning, mechanical properties testing, and regulatory support integrated with manufacturing partnerships.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

Confluent Medical is a contract development and manufacturing organization (CDMO) that produces Nitinol components and tubing, advanced polymer tubing (PTFE and polyimide), biomedical textiles, and complex catheter assemblies for medical device OEMs. The company operates a vertically integrated supply chain spanning Nitinol alloy melt (via ATI partnership) through precision laser machining and component fabrication to finished catheter and implant assemblies, serving cardiovascular, neurovascular, electrophysiology, peripheral vascular, and structural heart applications from concept through commercialization.

Product overview

Confluent Medical Technologies is a contract development and manufacturing organization (CDMO) providing vertically integrated manufacturing for medical devices. Their portfolio includes Nitinol Components (laser-cut stents, frames, wireforms), Nitinol Tubing and Wire (SE508 ELI high-purity alloys), Polymer Tubing (FilmCast PTFE, polyimide including Ultra Polyimide, and FilmCast Select customization program), Complex Catheters, Balloon Catheters, Biomedical Textiles (wovens, knits, braids, electrospun), Polymer Stent Coverings (ePTFE, TPU), and Catheter Components. These capabilities are integrated from concept through commercialization with a vertically integrated supply chain spanning alloy melt to finished device assembly.

Differentiator

Problem solved

Functional benefit

Brands

• Filmcast Select: Materials customization program enabling OEMs to select key performance attributes of Filmcast PTFE and polyimide tubing
• Ultra Polyimide
• Ultra PI
• FlexaCast
• DuraCast
• UltraCast
• SE508 ELI
• CALADR应X Hybrid Textiles

Products and services

• Nitinol Components Precision laser-cut Nitinol components including stents, frames, wireforms, and custom laser-machined parts manufactured for structural heart, neurovascular, electrophysiology, and peripheral vascular medical device applications.
• Nitinol Tubing and Wire Medical-grade Nitinol tubing, hypotubes, and wire including SE508 and SE508 ELI high-purity alloys engineered for high-fatigue implant applications with industry-leading 4-6 week lead times.
• Polymer Tubing High-precision polymer tubing including FilmCast PTFE, polyimide (standard, glossy REACH, matte REACH, and Ultra Polyimide variants), and composite constructions with 3-4 week lead times.
• Complex Catheters Complex catheter assembly and manufacturing services including shaft construction, steerability, torque response, and flex circuit integration for PFA, ablation, and electrophysiology catheters.
• Balloon Catheters Balloon catheter design and manufacturing including PTA balloons and constructions using Pebax, Grilamid, HDPE trilayer, and Pellethane materials for cardiovascular and peripheral vascular applications.
• Biomedical Textiles Implantable textiles including wovens, knits, braids, non-wovens, and electrospun materials (including CALADRIX Hybrid Textiles) for cardiovascular, neurovascular, and structural heart devices.
• Polymer Stent Coverings Polymer stent coverings including ePTFE coating, TPU dip coating, and laser cutting services for vascular and endovascular devices with tunable internodal distance (30-100µm) and thickness (100-250µm).
• Catheter Components Sheaths, dilators, and other catheter components manufactured for device delivery systems.
• Extrusion Services In-house polymer and Nitinol extrusion capabilities for tubing, wire, and custom profiles as part of the vertically integrated manufacturing platform.
• Ultra Polyimide Tubing Next-generation polyimide tubing with approximately 2x the tensile and column strength of traditional polyimide formulations, NMP-Free and REACH compliant, launched April 2025.
• FilmCast Select Materials Customization Program Materials customization program enabling OEMs to define key properties of FilmCast PTFE and polyimide tubing including flexibility, strength, surface finish, and regulatory compliance from development onset, launched January 2026.
• FilmCast Select PTFE Variants (FlexaCast, DuraCast, UltraCast) Three specialized FilmCast Select PTFE variants: FlexaCast (more than 2x elongation of ram-extruded PTFE for tortuous anatomy), DuraCast (higher abrasion resistance for durability during multiple exchanges), and UltraCast (higher tensile strength minimizing wrinkling under high mechanical loads), launched February 2026.
• Nitinol Wire Center of Excellence Center of Excellence announced May 2026 to strengthen Nitinol supply chain and wire capabilities, supporting medical device OEMs with vertically integrated wire processing and manufacturing.

Quantifiable outcome

• 50-70% cost savings on component tolerance redesign projects
• +3 more outcomes

Named customers2 records

Segments6 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Two partnerships are on record, tiered core and supporting.

• ATIcoreStrategic or Co-development Partner · 1 January 2024Strategic partnership announced January 2024 where Confluent and ATI invested over $50 million to triple ATI's medical Nitinol melt capacity. Confluent serves as ATI's fulfillment partner providing value-added services and order fulfillment for ATI's medical-grade Nitinol mill products. This partnership addresses critical supply chain needs with capacity increases on a quarterly basis, aiming to increase capacity by over 300% by 2027. Confluent is ATI's commercial arm for medical Nitinol.
• The Electrospinning CompanysupportingTechnology or IntegrationPartnership to provide CALADRIX® Hybrid Textiles - suture-less medical device coverings using electrospinning technology. The partnership enables enhanced tissue integration, preserved textile strength, control over permeability, ultra-low profile, and flexibility for cardiovascular, neurovascular, orthopedic, and general surgery applications.

Scale indicators10 records

Recent moves11 records

Expansion highlights6 records

Direct peers

• Cirtec Medical: Cirtec Medical is a PE-backed medical device CDMO focused on minimally invasive and interventional devices, with capabilities in catheter manufacturing, Nitinol processing, and electronic components for active implantable devices — directly overlapping with Confluent's complex catheter and electrophysiology OEM focus.
• Resonetics: Resonetics is a privately held medical device CDMO specializing in Nitinol laser-cut components, metal tubing, and intricate interventional device manufacturing — directly overlapping with Confluent's Nitinol components and laser-cutting capabilities. Both serve cardiovascular, neurovascular, and structural heart OEMs.
• Integer Holdings: Integer Holdings is one of the largest medical device CDMOs, with a portfolio spanning interventional cardiology, neuromodulation, and structural heart components — the same OEM customer segments Confluent serves. Integer's vertical integration across manufacturing and assembly, plus its scale (significantly larger than Confluent), makes it the closest publicly traded comparable.
• Biomerics: Biomerics is a specialty medical device CDMO with comparable capabilities in Nitinol processing, polymer extrusion, and catheter assembly for interventional markets. Its vertical integration across materials, components, and finished devices mirrors Confluent's stack for similar OEM customers.
• Trelleborg Healthcare & Medical: Trelleborg's Healthcare & Medical business manufactures polymer and silicone-based components and assemblies for medical device OEMs, including catheter applications. Its scale and global footprint offer a comparable business model to Confluent's polymer and catheter capabilities.
• Tegra Medical: Tegra Medical is a medical device contract manufacturer specializing in complex catheter and Nitinol component production for interventional applications, with services spanning prototyping, manufacturing, and finishing — directly comparable to Confluent's core complex-catheter and Nitinol offerings.
• Spectrum Plastics Group: Spectrum Plastics Group is a specialty plastics-focused CDMO serving medical device OEMs with injection molding, extrusion, and catheter capabilities — directly comparable to Confluent's polymer tubing, balloon catheter, and polymer stent covering offerings.

Broad incumbents

• Heraeus Medical Components: Heraeus Medical Components is a global, multi-product medical device components manufacturer with extensive capabilities in Nitinol, precious metals, polymers, and coatings for major OEMs. While broader and more diversified than Confluent, it competes in the same component supplier landscape for cardiovascular and neurovascular devices.
• Teleflex Medical OEM: Teleflex Medical OEM provides custom-engineered medical devices, extrusions, and catheter-based solutions to medical device OEMs. As a larger, publicly-traded incumbent with broader product and service depth, it overlaps with Confluent's polymer extrusion and catheter OEM-supply work.
• Nordson Medical: Nordson Medical is a broader medical device manufacturing solutions provider with capabilities spanning fluid management, precision dispensing, and catheter manufacturing solutions. It overlaps with Confluent's catheter and extrusion capabilities but operates a wider portfolio rather than a focused Nitinol/CDMO position.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/ConfluentMed
• YouTubeyoutube.com/channel/UCGf8CQnvV3ainxkKneTaP6A
• Facebookfacebook.com/ConfluentMedical
• LinkedInlinkedin.com/company/confluent-medical-technologies

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Confluent Medical